Targeted Tuberculosis Contact Investigation Saves Money Without Sacrificing Health
Authors:
- 1 July 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 15 (4) , 319-327
Abstract
Background Health departments require an efficient strategy to investigate individuals exposed to Mycobacterium tuberculosis. The contact priority model (CPM) uses a decision rule to minimize testing of low-risk contacts; however, its impact on costs and disease control is unknown. Methods A cost-effectiveness analysis compared the CPM with the traditional concentric circle approach (CCA) in a simulated population of 1000 healthy, community-dwelling adults with a 10% background rate of latent tuberculosis (TB) infection. The analysis was conducted from the perspective of the Alabama Department of Public Health. Model inputs were derived from the literature and the Alabama Department of Public Health. Lifetime costs (2004 dollars) and outcomes were discounted 3 percent annually. Incremental cost-effectiveness ratios were used to compare the strategies. Results Over the lifetime of 1000 simulated contacts, the CPM saved $45 000 but led to 0.5 additional TB cases and 0.24 fewer years of life. The CCA is more effective than the CPM, but it costs $92 934 to prevent one additional TB case and $185 920 to gain one additional life year. Conclusions The CPM reduces costs with minimal loss of disease control and is a viable alternative to the CCA under most conditions.Keywords
This publication has 25 references indexed in Scilit:
- An Official ATS Statement: Hepatotoxicity of Antituberculosis TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.2005
- Screening and Treatment of Latent Tuberculosis Among Healthcare Workers at Low, Moderate, and High Risk for Tuberculosis Exposure: A Cost-Effectiveness AnalysisInfection Control & Hospital Epidemiology, 2004
- Hospitalizations for Tuberculosis in the United States in 2000Chest, 2004
- Short‐Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Cost‐Effectiveness Analysis Based on a Multicenter Clinical TrialClinical Infectious Diseases, 2004
- A Decision Tree for Tuberculosis Contact InvestigationAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Outcomes of Contact Investigations of Infectious Tuberculosis PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Hepatotoxicity Associated With Isoniazid Preventive TherapyJAMA, 1999
- Isoniazid for the Tuberculin Reactor: Take It or Leave ItAmerican Review of Respiratory Disease, 1988
- The Age Threshold for Isoniazid ChemoprophylaxisJAMA, 1986